REXPRIDE GMP2 (Glimepiride, Pioglitazone & Metformin HCl (SR) Tablets) - Anti-diabetic formulation packaging box | RexCure Pharma
Anti-diabetic
Schedule H Rx
Genuine RexCure Batch PackagingImage 1 of 2
Diabetology & Metabolic CareFilm-coated TabletsSchedule H Rx

REXPRIDE GMP2

Glimepiride, Pioglitazone & Metformin HCl (SR) Tablets

Triple-action anti-diabetic formulation targeting peripheral insulin resistance and sustained glycemic control.

Strength

2 mg + 15 mg + 500 mg

Commercial Pack

Strip of 10 Tablets

Indicative MRP

Rs. 110.00

Drug Class

Schedule H Rx

Active Chemical Composition

Each film-coated tablet contains:

  • Glimepiride 2 mg
  • Pioglitazone Hydrochloride 15 mg
  • Metformin Hydrochloride (SR) 500 mg
  • Excipients q.s.

Primary Clinical Indications

1

Type 2 Diabetes Mellitus with insulin resistance

2

Glycemic control in difficult-to-manage cohorts

Therapeutic Pharmacology & Overview

REXPRIDE GMP2 combines Glimepiride, Pioglitazone (PPAR-gamma agonist addressing peripheral insulin sensitivity), and Metformin HCl SR for patients requiring comprehensive metabolic stabilization.

Key Formulation Advantages

Directly enhances peripheral insulin sensitivity and glucose uptake
Reduces hepatic gluconeogenesis via sustained-release Metformin
Physiological insulin secretagogue support via Glimepiride
Convenient once-daily dosing regimen

Dosage & Administration

Standard Adult / Pediatric Regimen:

Swallowed whole with breakfast or first main meal, as directed by physician.

Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.

Packaging & Storage Details

Commercial Presentation:

10 × 10 Alu-Alu Strip in box

Storage Monograph:

Store in a dry place at a temperature not exceeding 25°C

Market Authorization Holder:

RexCure Pharmaceuticals Pvt. Ltd.

Hyderabad, Telangana

Clinical Inquiry / Sample Request

Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.

Contact Medical Desk

Drug Law Compliance

Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.
Segment Portfolio

Related Formulations in Diabetology & Metabolic Care

View Area (All) →
VOGLIREX-VM 2.2 (Glimepiride, Metformin HCl (SR) & Voglibose Tablets) - Anti-diabetic formulation packaging by RexCure Pharma
Bilayered Tablets

VOGLIREX-VM 2.2

Glimepiride, Metformin HCl (SR) & Voglibose Tablets

View Product Profile